Sally Mossman, VP, Vaccines R&D and Head Discovery Performance Unit at GSK, joins BioTalk to discuss their Rockville location, why the BioHealth Capital Region is right for the GSK, and their role in the development of a COVID-19 Vaccine.
Want to check another podcast?
Enter the RSS feed of a podcast, and see all of their public statistics.
This website doesn't track the visitors or use any cookies. Made by Alex Barredo. Send your feedback to alex@barredo.es.